| | |
| Chavez's breathing problems worsen, has severe new infection Monday, Mar 04, 2013 08:04 PM PST | Top |
| Washington state lawmaker backpedals after saying cyclists pollute by breathing Monday, Mar 04, 2013 07:40 PM PST SEATTLE (Reuters) - A Washington state lawmaker has apologized for telling a bike store owner, in a spat over a proposed bike fee, that bicyclists can cause pollution - just by breathing out carbon dioxide. Ed Orcutt, a ranking Republican member of the state House of Representatives Transportation committee, said in an email exchange with a bike shop owner that drivers and bicyclists should both share the burden of preserving the roads they use. ... Full Story | Top |
| Budget crisis eases as Republicans seek to avoid shutdown Monday, Mar 04, 2013 06:41 PM PST | Top |
| Monster Beverage says its energy drinks did not kill teen Monday, Mar 04, 2013 05:04 PM PST | Top |
| After latest budget battle, Obama calls senators looking for common ground Monday, Mar 04, 2013 04:58 PM PST | Top |
| Impax shares drop as FDA flags new concerns on manufacturing plant Monday, Mar 04, 2013 04:46 PM PST (Reuters) - Impax Laboratories Inc said U.S. health regulators raised fresh concerns related to manufacturing practices at the drugmaker's Hayward, California facility, sending its shares down more than 20 percent after the bell. The company's hopes of securing an approval for its Parkinson's drug Rytari are tied to its ability to resolve issues at the plant, where the drug is partly manufactured. The U.S. ... Full Story | Top |
| FDA denies approval to expanded use of J&J/Bayer's Xarelto Monday, Mar 04, 2013 04:40 PM PST (Reuters) - Johnson & Johnson said health regulators denied approval to an expanded use of its blood thinner, Xarelto, to reduce the risk of heart attacks and strokes in patients with acute coronary syndrome. The drug, which J&J has developed in partnership with German drugmaker Bayer AG, was earlier denied approval in June for the same use, as a panel to the U.S. Food and Drug Administration raised concerns about missing trial data and bleeding risks. ... Full Story | Top |
| Childhood ADHD may lead to troubles later on in life Monday, Mar 04, 2013 04:14 PM PST (Reuters) - Nearly a third of people diagnosed as children with attention deficit hyperactivity disorder (ADHD) still have the condition in adulthood, according to a U.S. study of thousands. The researchers, whose findings appeared in Pediatrics, also found that these people were more likely to develop other mental disorders, such as anxiety or depression, and commit suicide. ... Full Story | Top |
| AcelRx post-operative pain treatment meets late-stage study goal Monday, Mar 04, 2013 04:11 PM PST (Reuters) - AcelRx Pharmaceuticals Inc said its experimental drug-device combination to manage post-operative pain met the main goal of a late-stage study on patients who have undergone major open abdominal surgery. The Redwood City, California company's shares jumped 10 percent to $5.49 after the bell on Monday. The top-line results, reported from a 178-patient study of AcelRx's Sufentanil NanoTab patient-controlled analgesia (PCA) system, showed that the drug-device combination helped reduce pain significantly compared with a placebo, the company said. ... Full Story | Top |
| Despite free treatment, British health rankings decline Monday, Mar 04, 2013 04:09 PM PST | Top |
| Republicans move to avoid government shutdown Monday, Mar 04, 2013 03:52 PM PST | Top |
| FDA advisors vote against two drugs for menopausal hot flashes Monday, Mar 04, 2013 03:35 PM PST | Top |
| AcelRx pain treatment meets late-stage study goal Monday, Mar 04, 2013 03:25 PM PST (Reuters) - AcelRx Pharmaceuticals Inc said its experimental drug-device combination for post-operative pain met the main goal of a late-stage study on patients who have undergone major open abdominal surgery. AcelRx shares jumped 10 percent to $5.49 after the bell on Monday. The top-line results reported from a 178-patient study of AcelRx's sublingual Sufentanil NanoTab PCA system showed that the patient-controlled drug-device combination helped reduce pain significantly compared with a placebo, the company said. (Reporting by Zeba Siddiqui in Bangalore; Editing by Roshni Menon) Full Story | Top |
| Arkansas governor vetoes bill banning most abortions at 12 weeks Monday, Mar 04, 2013 02:41 PM PST LITTLE ROCK, Arkansas (Reuters) - Democratic Governor Mike Beebe on Monday vetoed legislation that would ban most abortions in Arkansas after 12 weeks of pregnancy, a restriction that would be the most severe in the nation. The bill's supporters say they plan to seek a vote on Tuesday to override Beebe's veto, which would require only a simple majority in Arkansas. Beebe said in a veto letter that the bill "blatantly contradicts" the U.S. Constitution as interpreted by the Supreme Court, and he questioned the potential cost to taxpayers of defending it against legal challenges. ... Full Story | Top |
| Yankees GM breaks leg in parachute jump for charity Monday, Mar 04, 2013 02:40 PM PST | Top |
|

No comments:
Post a Comment